Joseph Bratica is Principal Financial Officer of Sarepta Therapeutics, Inc.. Currently has a direct ownership of 8,140 shares of SRPT, which is worth approximately $859,258. The most recent transaction as insider was on Dec 11, 2020, when has been sold 1,115 shares (Common Stock) at a price of $165.0 per share, resulting in proceeds of $183,975. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 8.14K
0% 3M change
0% 12M change
Total Value Held $859,258

Joseph Bratica Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 11 2020
SELL
Open market or private sale
$183,975 $165.0 p/Share
1,115 Reduced 12.05%
8,140 Common Stock
Dec 11 2020
BUY
Exercise of conversion of derivative security
$79,667 $71.45 p/Share
1,115 Added 10.75%
9,255 Common Stock
Dec 08 2020
SELL
Open market or private sale
$180,000 $160.0 p/Share
1,125 Reduced 12.14%
8,140 Common Stock
Dec 08 2020
BUY
Exercise of conversion of derivative security
$33,300 $29.6 p/Share
1,125 Added 10.83%
9,265 Common Stock
JB

Joseph Bratica

Principal Financial Officer
Cambridge, MA

Track Institutional and Insider Activities on SRPT

Follow Sarepta Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SRPT shares.

Notify only if
Any

Insider Trading

Get notified when an Sarepta Therapeutics, Inc. insider buys or sells SRPT shares.

Notify only if
Any
Any
P - Open market or private purchase×
S - Open market or private sale×
V - Transaction voluntarily reported earlier than required×
A - Grant, award, or other acquisition×
D - Sale (or disposition) back to the issuer×
F - Payment of exercise price or tax liability×
I - Discretionary transaction×
M - Exercise of conversion of derivative security×
C - Conversion of derivative security×
E - Expiration of short derivative position×
H - Expiration (or cancellation) of long derivative position with value received×
O - Exercise of out-of-the-money derivative securities×
X - Exercise of in-the-money or at-the-money derivatives securities×
G - Bona fide gift×
L - Small Acquisition×
W - Acquisition or disposition by will or laws×
Z - Deposit into or withdrawal from voting trust×
J - Other acquisition or disposition×
K - Transaction in equity swap or similar instrument×
U - Disposition due to a tender of shares in a change of control transaction×
20 item(s) selected

News

Receive news related to Sarepta Therapeutics, Inc.

Track Activities on SRPT